Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Clinical trial NCT06648057 · RECRUITING

Trial details

NCT number: NCT06648057
Sponsor: CHA University
Status: RECRUITING
Study type: OBSERVATIONAL

Biliary Tract Cancer Cholangiocarcinoma

Start date: 2024-09-23
Primary completion: 2026-09-23
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.